Skip to main content
Premium Trial:

Request an Annual Quote

Roche NimbleGen, Signature Genomic Laboratories

Premium
Roche NimbleGen last week launched its Gene Expression 12x135K Microarray format, a new multiplex gene expression array on its HD2 platform.
 
The 12-plex format enables users to analyze 12 independent samples simultaneously on a single slide, the company said. With 135,000 long oligonucleotide probes per array, complete transcriptome coverage can also be achieved.
 
NimbleGen is offering eight eukaryotic catalog designs in the new format – human, mouse, rat, A. thaliana, C. elegans, D. melanogaster, S. cerevisiae, and S. pombe. The company said it also offers custom-designed arrays in the new format.
 

 
Signature Genomic Laboratories last week announced that it has waived the 25 percent deposit previously required of patients for insurance billing.
 
Rather than pay a deposit prior to the initiation of testing, patients with private insurance can now request an insurance benefits investigation prior to or concurrent with sample processing through Signature's Patient Advocacy Program. Signature's patient advocacy team will communicate with the patient's insurance carrier on the patient's behalf to determine coverage.
 
Signature offers array-based cytogenetics testing for mental retardation and birth defects through its lab in Spokane, Wash.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.